Early experience with the new DORA daridorexant in patients with insomnia disorder and comorbid mental disturbances: Results of a naturalistic study with 3 months follow‐up

Summary Insomnia disorder may affect mental health, increasing suicidal risk. Targeting insomnia is crucial in the clinical practice. Sixty‐six consecutive patients with insomnia disorder according with the DSM‐5‐TR criteria were treated with the dual orexin receptor antagonist, daridorexant 50 mg....

Full description

Saved in:
Bibliographic Details
Published in:Journal of sleep research 2024-12, Vol.33 (6), p.e14196-n/a
Main Authors: Palagini, Laura, Alfi, Gaspare, Gurrieri, Riccardo, Annuzzi, Eric, Caruso, Valerio, Gambini, Matteo, Grenno, Giovanna, Trivella, Marco, Presta, Silvio, Miniati, Mario, Pini, Stefano, Perugi, Giulio, Gemignani, Angelo
Format: Article
Language:English
Subjects:
Adult
Aged
anxiety
Anxiety - drug therapy
Anxiety Disorders - complications
Anxiety Disorders - drug therapy
Anxiety Disorders - epidemiology
Comorbidity
daridorexant
depression
dual orexin receptor antagonist
Female
Follow-Up Studies
Humans
insomnia
insomnia therapy
Male
Mental Disorders - complications
Mental Disorders - drug therapy
Mental Disorders - epidemiology
Middle Aged
Orexin Receptor Antagonists - pharmacology
Orexin Receptor Antagonists - therapeutic use
Psychiatric Status Rating Scales
Severity of Illness Index
Sleep Initiation and Maintenance Disorders - drug therapy
Suicidal Ideation
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Insomnia disorder may affect mental health, increasing suicidal risk. Targeting insomnia is crucial in the clinical practice. Sixty‐six consecutive patients with insomnia disorder according with the DSM‐5‐TR criteria were treated with the dual orexin receptor antagonist, daridorexant 50 mg. Baseline (T0), 1 month (T1) and 3 month (T2) evaluations were performed. Insomnia severity (Insomnia Severity Index), mood, anxiety symptoms and suicidal risk (Beck Depression Inventory‐II, Young Mania Rating Scale, Self‐Reported Anxiety Scale, Suicidal Ideation Scale), dysfunctional insomnia‐cognitive factors and pre‐sleep arousal (Dysfunctional Beliefs About Sleep, Pre‐Sleep Arousal Scale) were evaluated. The final sample included 66 patients (n = 36, 54% females, mean age 60 ± 13.6 years). Most of them, 64%, suffered from insomnia disorder comorbid with unipolar/bipolar depression, anxiety disorders and substance use disorders. Repeated ANOVA analyses showed that Insomnia Severity Index, Dysfunctional Beliefs About Sleep and Pre‐Sleep Arousal Scale total score decreased across time (F = 68.818, p 
ISSN:0962-1105
1365-2869
1365-2869
DOI:10.1111/jsr.14196